| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 198.30M | 144.90M | 134.90M | 133.60M | 123.70M |
| Gross Profit | 189.10M | 141.90M | 131.00M | 90.00M | 150.62M |
| EBITDA | -191.40M | 110.10M | -153.70M | -130.50M | 97.90M |
| Net Income | 51.30M | 52.10M | 49.90M | 44.00M | 51.10M |
Balance Sheet | |||||
| Total Assets | 34.08B | 29.16B | 24.71B | 22.43B | 23.29B |
| Cash, Cash Equivalents and Short-Term Investments | 268.40M | 200.70M | 200.30M | 186.10M | 1.45B |
| Total Debt | 20.00M | 9.40M | 1.10M | 2.80M | 7.36M |
| Total Liabilities | 33.85B | 28.95B | 24.52B | 22.26B | 23.12B |
| Stockholders Equity | 224.90M | 208.30M | 189.90M | 173.20M | 163.27M |
Cash Flow | |||||
| Free Cash Flow | 335.90M | 276.30M | 6.50M | 235.90M | -56.90M |
| Operating Cash Flow | 340.50M | 277.20M | 7.20M | 236.30M | -56.24M |
| Investing Cash Flow | -28.40M | 29.40M | -14.40M | 400.00K | -9.35M |
| Financing Cash Flow | -39.90M | -36.80M | -37.10M | -37.90M | -31.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £2.40B | 20.62 | 8.35% | 3.40% | -28.04% | -102.43% | |
72 Outperform | £1.04B | 22.35 | 23.86% | 3.11% | 7.13% | -1.52% | |
72 Outperform | £210.75M | 13.32 | 7.58% | 5.14% | -13.29% | 63.87% | |
70 Outperform | £2.09B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £2.21B | 52.21 | -3.61% | 1.03% | 16.90% | -165.00% | |
65 Neutral | £1.92B | 10.20 | 49.89% | 2.43% | 17.97% | 25.51% |